Freshfields advised Indivior PLC on its additional listing on NASDAQ. Indivior PLC (LSE: INDV), a global pharmaceutical company focused on developing medicines to treat substance use disorders (SUD)...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here